Recombinant HIV-1 protease in bacteria
Company
Veritas, Inc.
Use
Used for designing HIV protease inhibitors, which serves as an important component of combination therapies for HIV
Features
Can possibly be used in the treatment of patients with AIDS
NIH Contribution
Discovered human immunodeficiency virus specific proteolytic enzyme and developed method for synthesis and renaturation
HHS Institute/Agency
NCI
Inventor(s)
S. Oroszlan, T. Copeland
Year
1995
Tech Cat
Research Reagent
Request More Info
